BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
12.31
+0.13 (1.07%)
Nov 28, 2025, 4:00 PM EST - Market closed
BBOT Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$24.75
Upside
+101.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Reiterates $25 | Buy | Reiterates | $25 | +103.09% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $23 → $22 | Buy | Maintains | $23 → $22 | +78.72% | Nov 13, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $25 | Buy | Initiates | $25 | +103.09% | Sep 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $27 | Strong Buy | Initiates | $27 | +119.33% | Sep 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $23 | Buy | Initiates | $23 | +86.84% | Sep 4, 2025 |
| Wedbush | Wedbush | Buy Initiates $25 | Buy | Initiates | $25 | +103.09% | Aug 18, 2025 |